Clinical Trial Update: A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

A randomized Phase 2 pharmacokinetic trial evaluated chemotherapy with or without panitumumab in metastatic/recurrent squamous cell carcinoma of the head and ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of Head and Neck

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Amgen | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2013-12-13